Irving-based ShiftKey earned a $2 billion valuation following a $300 million funding round, according to Axios. ShiftKey’s tech allows healthcare professionals to connect directly with industry facilities in need of shift workers. It’s used in more than 10,000 healthcare facilities nationwide.
The startup’s capital raise was led by Lorient Capital through a continuation vehicle guided by the Ares Management Secondaries funds and Pantheon. Additional investors include Clearlake Capital and Health Velocity Capital.
“Nurses continue to choose to work on their own terms,” said Tom Ellis, founder and CEO of ShiftKey. “Our vision is to empower nurses and other licensed professionals through the combination of our core marketplace product, along with additional technology and tools such as scheduling, payments, education, and credentialing.”
According to ShiftKey, since its founding in 2016, the platform has scheduled 57 million working hours.
Healthcare Startup Medix Infusion Raises $35 Million in Series B Funding
Dallas-based Medix Infusion, a healthcare startup which creates access to infusion therapy for patients in underserved markets, recently closed a $35 million Series B funding round. Led by Echo Health Ventures, the new funding will support organic growth and the acquisition of the infusion operations of the Center for Neurology and Spine, an Arizona facility that treats neurological disorders.
Additional investors include Pittco Direct Investments II and Noro-Moseley Partners. For further growth, Medix Infusion also entered into a debt facility with Live Oak Bank.
“We are thankful for the confidence in our company and its vision demonstrated by our new partners, Echo Health Ventures and Pittco, and energized by the continued trust of Noro-Moseley Partners through another round of investment,” said Medix Infusion CEO Gus de Avillez. “Together, we can unlock new strategic opportunities to reduce the overall cost of care and create greater access to convenient, compassionate infusion care in underserved communities across the country.”
Medix Infusion, which was founded in April of 2020, has seen doubled year-over-year since its launch. With its latest acquisition of the Center for Neurology and Spine, the company now operates more than 30 locations across five states along with its home infusion pharmacy operations, impacting more than 4,600 patients.
Worlds Raises More than $21 Million in Series A1 Funding
Worlds Enterprises, creators of a new 4D infrastructure for building the Industrial Metaverse, recently closed a $21.2 million Series A1 funding round. Led by California-based Moneta Ventures with participation from: Dallas-based firms Align Capital, Green Park & Golf Ventures, and PerotJain; Houston-based Chevron Technology Ventures; San Francisco-based Piva Capital; and Austin-based Capital Factory. The new funding will be used to invest in the company’s AI platform, expand go-to-market partnerships, and further grow Worlds’ adoption by industrial companies.
“We are thrilled that Moneta and all of our investors share our vision for large-scale digital transformation and believe in the incredible potential of Worlds as much as we do,” said Dave Copps, CEO of Worlds. “Businesses today are racing toward a future where the digital and physical worlds fully converge and radically change how they measure, analyze, and reimagine their businesses. That is precisely the work of Worlds, and we are the only company on the planet that can do what we do.”
The Worlds Industrial Metaverse platform allows large industrial companies to bring AI-based automation into ground-floor operations. Its clients include Chevron, Petronas, and Hillwood Development Co.
Worlds—which launched in August 2021—saw more than 400 percent year-over-year growth of annual recurring revenue in 2022.
Author
